Influenza Vaccine Market Size and Analysis Report 2022-2028

Report Overview
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Global Influenza Vaccine main players include CSL, GSK, Sanofi Pasteur, Mylan, Hulan Bio, AstraZeneca, CCBIO, etc., totally accounting for about 95% of market. North America is the largest market of Influenza Vaccine, with a share over 55%. As for the types of products, it can be divided into Trivalent Influenza Vaccine and Quadrivalent Influenza Vaccine. The most common product is Quadrivalent Influenza Vaccine, with a share over 95%. In terms of applications, it is widely used in For Children (6 months to 3 years) and For Adults and Children over 3 years. The most application is in Adults and Children over 3 years, with a share over 73%.
The Global Influenza Vaccine Market Size was estimated at USD 5159.67 million in 2021 and is projected to reach USD 6716.08 million by 2028, exhibiting a CAGR of 3.84% during the forecast period.
The latest report provides a deep insight into the global Influenza Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Influenza Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Influenza Vaccine market in any manner.
Global Influenza Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company
•CSL
•GSK
•Sanofi Pasteur
•Mylan
•Hulan Bio
•AstraZeneca
•CCBIO

Market Segmentation (by Type)
•Trivalent Influenza Vaccine
•Quadrivalent Influenza Vaccine

Market Segmentation (by Application)
•For Children (6 months to 3 years)
•For Adults and Children over 3 years

Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Influenza Vaccine Market
• Overview of the regional outlook of the Influenza Vaccine Market:

Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

FAQ

The Influenza Vaccine market research report includes specific segments by region (country), i.e. North America, Europe, Asia Pacific, South America, Middle East and Africa

The Influenza Vaccine market report provides global companies with an opportunity to enter new markets, invest in new sectors, analyze consumer reactions, investigate global competition, and ultimately make smart investments.

Influenza Vaccine report covers the latest market developments in terms of acquisitions, growth strategies, joint ventures and collaborations, new product launches, and more on industry.

We can provide customization on reports prior to the sale. If you need customization we request you to provide specific details on customization prior to the dispatch. This is because we move fast with your queries as it requires a lot of diligence. There will be additional charges for customization once the report is dispatched to you and will be treated as post-sales query.

Requesting a Sample copy of the report from Xcellent Insights is hassle-free! You can either request it from the report page or call our sales Executive at US: +1 408 627 7717 /UK: +44 208 638 6439 and share/discuss your requirements. Our Team will share the sample copy of the report with you within 12 Working Hours / Shortly.

Ordering a report from Xcellent Insights is hassle-free! You can select a licence type that suits your requirement and proceed to checkout. It will redirect you to the payment gateway with a list of payment options. Be rest assured that we do not store the payment details. Once we receive the payment, a confirmation email will be sent on your registered mail id with details on the report delivery timeline. You can also get your order placed through our business development executives and they will guide you thoroughly.

You should buy this report from Xcellent Insights for a better clarity on market scenarios.
The market report has been prepared using a pragmatic approach to suit your needs.
We have an extensive library of reports that can help you understand the market landscape and make informed decisions about your business.
Additionally, the reports are written by experienced analysts who have a deep understanding of the market and the latest trends.
Besides, customization is a value-added service if you decide to opt.

Table of Content

1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Influenza Vaccine
1.2 Key Market Segments
1.2.1 Influenza Vaccine Segment by Type
1.2.2 Influenza Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Influenza Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Influenza Vaccine Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Influenza Vaccine Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Influenza Vaccine Market Competitive Landscape
3.1 Global Influenza Vaccine Sales by Manufacturers (2017-2022)
3.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.3 Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Influenza Vaccine Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Influenza Vaccine Sales Sites, Area Served, Product Type
3.6 Influenza Vaccine Market Competitive Situation and Trends
3.6.1 Influenza Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Influenza Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Influenza Vaccine Industry Chain Analysis
4.1 Influenza Vaccine Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Influenza Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Influenza Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Vaccine Sales Market Share by Type (2017-2022)
6.3 Global Influenza Vaccine Market Size Market Share by Type (2017-2022)
6.4 Global Influenza Vaccine Price by Type (2017-2022)
7 Influenza Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Vaccine Market Sales by Application (2017-2022)
7.3 Global Influenza Vaccine Market Size (M USD) by Application (2017-2022)
7.4 Global Influenza Vaccine Sales Growth Rate by Application (2017-2022)
8 Influenza Vaccine Market Segmentation by Region
8.1 Global Influenza Vaccine Sales by Region
8.1.1 Global Influenza Vaccine Sales by Region
8.1.2 Global Influenza Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Influenza Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Influenza Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Influenza Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Influenza Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Influenza Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 CSL
9.1.1 CSL Influenza Vaccine Basic Information
9.1.2 CSL Influenza Vaccine Product Overview
9.1.3 CSL Influenza Vaccine Product Market Performance
9.1.4 CSL Business Overview
9.1.5 CSL Influenza Vaccine SWOT Analysis
9.1.6 CSL Recent Developments
9.2 GSK
9.2.1 GSK Influenza Vaccine Basic Information
9.2.2 GSK Influenza Vaccine Product Overview
9.2.3 GSK Influenza Vaccine Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Influenza Vaccine SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi Pasteur
9.3.1 Sanofi Pasteur Influenza Vaccine Basic Information
9.3.2 Sanofi Pasteur Influenza Vaccine Product Overview
9.3.3 Sanofi Pasteur Influenza Vaccine Product Market Performance
9.3.4 Sanofi Pasteur Business Overview
9.3.5 Sanofi Pasteur Influenza Vaccine SWOT Analysis
9.3.6 Sanofi Pasteur Recent Developments
9.4 Mylan
9.4.1 Mylan Influenza Vaccine Basic Information
9.4.2 Mylan Influenza Vaccine Product Overview
9.4.3 Mylan Influenza Vaccine Product Market Performance
9.4.4 Mylan Business Overview
9.4.5 Mylan Influenza Vaccine SWOT Analysis
9.4.6 Mylan Recent Developments
9.5 Hulan Bio
9.5.1 Hulan Bio Influenza Vaccine Basic Information
9.5.2 Hulan Bio Influenza Vaccine Product Overview
9.5.3 Hulan Bio Influenza Vaccine Product Market Performance
9.5.4 Hulan Bio Business Overview
9.5.5 Hulan Bio Influenza Vaccine SWOT Analysis
9.5.6 Hulan Bio Recent Developments
9.6 AstraZeneca
9.6.1 AstraZeneca Influenza Vaccine Basic Information
9.6.2 AstraZeneca Influenza Vaccine Product Overview
9.6.3 AstraZeneca Influenza Vaccine Product Market Performance
9.6.4 AstraZeneca Business Overview
9.6.5 AstraZeneca Recent Developments
9.7 CCBIO
9.7.1 CCBIO Influenza Vaccine Basic Information
9.7.2 CCBIO Influenza Vaccine Product Overview
9.7.3 CCBIO Influenza Vaccine Product Market Performance
9.7.4 CCBIO Business Overview
9.7.5 CCBIO Recent Developments
10 Influenza Vaccine Market Forecast by Region
10.1 Global Influenza Vaccine Market Size Forecast
10.2 Global Influenza Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Influenza Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Influenza Vaccine Market Size Forecast by Region
10.2.4 South America Influenza Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Influenza Vaccine by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Influenza Vaccine Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Influenza Vaccine by Type (2022-2028)
11.1.2 Global Influenza Vaccine Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Influenza Vaccine by Type (2022-2028)
11.2 Global Influenza Vaccine Market Forecast by Application (2022-2028)
11.2.1 Global Influenza Vaccine Sales (K Units) Forecast by Application
11.2.2 Global Influenza Vaccine Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings

Tables and Figures
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Influenza Vaccine Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Influenza Vaccine Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Influenza Vaccine Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Influenza Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2021)
Table 10. Global Market Influenza Vaccine Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Influenza Vaccine Sales Sites and Area Served
Table 12. Manufacturers Influenza Vaccine Product Type
Table 13. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Influenza Vaccine
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Vaccine Market Challenges
Table 22. Market Restraints
Table 23. Global Influenza Vaccine Sales by Type (K Units)
Table 24. Global Influenza Vaccine Market Size by Type (M USD)
Table 25. Global Influenza Vaccine Sales (K Units) by Type (2017-2022)
Table 26. Global Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 27. Global Influenza Vaccine Market Size (M USD) by Type (2017-2022)
Table 28. Global Influenza Vaccine Market Size Share by Type (2017-2022)
Table 29. Global Influenza Vaccine Price (USD/Unit) by Type (2017-2022)
Table 30. Global Influenza Vaccine Sales (K Units) by Application
Table 31. Global Influenza Vaccine Market Size by Application
Table 32. Global Influenza Vaccine Sales by Application (2017-2022) & (K Units)
Table 33. Global Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 34. Global Influenza Vaccine Sales by Application (2017-2022) & (M USD)
Table 35. Global Influenza Vaccine Market Share by Application (2017-2022)
Table 36. Global Influenza Vaccine Sales Growth Rate by Application (2017-2022)
Table 37. Global Influenza Vaccine Sales by Region (2017-2022) & (K Units)
Table 38. Global Influenza Vaccine Sales Market Share by Region (2017-2022)
Table 39. North America Influenza Vaccine Sales by Country (2017-2022) & (K Units)
Table 40. Europe Influenza Vaccine Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Influenza Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. South America Influenza Vaccine Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Influenza Vaccine Sales by Region (2017-2022) & (K Units)
Table 44. CSL Influenza Vaccine Basic Information
Table 45. CSL Influenza Vaccine Product Overview
Table 46. CSL Influenza Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. CSL Business Overview
Table 48. CSL Influenza Vaccine SWOT Analysis
Table 49. CSL Recent Developments
Table 50. GSK Influenza Vaccine Basic Information
Table 51. GSK Influenza Vaccine Product Overview
Table 52. GSK Influenza Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. GSK Business Overview
Table 54. GSK Influenza Vaccine SWOT Analysis
Table 55. GSK Recent Developments
Table 56. Sanofi Pasteur Influenza Vaccine Basic Information
Table 57. Sanofi Pasteur Influenza Vaccine Product Overview
Table 58. Sanofi Pasteur Influenza Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Sanofi Pasteur Business Overview
Table 60. Sanofi Pasteur Influenza Vaccine SWOT Analysis
Table 61. Sanofi Pasteur Recent Developments
Table 62. Mylan Influenza Vaccine Basic Information
Table 63. Mylan Influenza Vaccine Product Overview
Table 64. Mylan Influenza Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Mylan Business Overview
Table 66. Mylan Influenza Vaccine SWOT Analysis
Table 67. Mylan Recent Developments
Table 68. Hulan Bio Influenza Vaccine Basic Information
Table 69. Hulan Bio Influenza Vaccine Product Overview
Table 70. Hulan Bio Influenza Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Hulan Bio Business Overview
Table 72. Hulan Bio Influenza Vaccine SWOT Analysis
Table 73. Hulan Bio Recent Developments
Table 74. AstraZeneca Influenza Vaccine Basic Information
Table 75. AstraZeneca Influenza Vaccine Product Overview
Table 76. AstraZeneca Influenza Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Recent Developments
Table 79. CCBIO Influenza Vaccine Basic Information
Table 80. CCBIO Influenza Vaccine Product Overview
Table 81. CCBIO Influenza Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. CCBIO Business Overview
Table 83. CCBIO Recent Developments
Table 84. Global Influenza Vaccine Sales Forecast by Region (K Units)
Table 85. Global Influenza Vaccine Market Size Forecast by Region (M USD)
Table 86. North America Influenza Vaccine Sales Forecast by Country (2022-2028) & (K Units)
Table 87. North America Influenza Vaccine Market Size Forecast by Country (2022-2028) & (M USD)
Table 88. Europe Influenza Vaccine Sales Forecast by Country (2022-2028) & (K Units)
Table 89. Europe Influenza Vaccine Market Size Forecast by Country (2022-2028) & (M USD)
Table 90. Asia Pacific Influenza Vaccine Sales Forecast by Region (2022-2028) & (K Units)
Table 91. Asia Pacific Influenza Vaccine Market Size Forecast by Region (2022-2028) & (M USD)
Table 92. South America Influenza Vaccine Sales Forecast by Country (2022-2028) & (K Units)
Table 93. South America Influenza Vaccine Market Size Forecast by Country (2022-2028) & (M USD)
Table 94. Middle East and Africa Influenza Vaccine Consumption Forecast by Country (2022-2028) & (Units)
Table 95. Middle East and Africa Influenza Vaccine Market Size Forecast by Country (2022-2028) & (M USD)
Table 96. Global Influenza Vaccine Sales Forecast by Type (2022-2028) & (K Units)
Table 97. Global Influenza Vaccine Market Size Forecast by Type (2022-2028) & (M USD)
Table 98. Global Influenza Vaccine Price Forecast by Type (2022-2028) & (USD/Unit)
Table 99. Global Influenza Vaccine Sales (K Units) Forecast by Application (2022-2028)
Table 100. Global Influenza Vaccine Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Influenza Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Vaccine Market Size (M USD), 2017-2028
Figure 5. Global Influenza Vaccine Market Size (M USD) (2017-2028)
Figure 6. Global Influenza Vaccine Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Vaccine Market Size (M USD) by Country (M USD)
Figure 11. Influenza Vaccine Sales Share by Manufacturers in 2020
Figure 12. Global Influenza Vaccine Revenue Share by Manufacturers in 2020
Figure 13. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Influenza Vaccine Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Influenza Vaccine Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Influenza Vaccine Market Share by Type
Figure 18. Sales Market Share of Influenza Vaccine by Type (2017-2022)
Figure 19. Sales Market Share of Influenza Vaccine by Type in 2021
Figure 20. Market Size Share of Influenza Vaccine by Type (2017-2022)
Figure 21. Market Size Market Share of Influenza Vaccine by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Influenza Vaccine Market Share by Application
Figure 24. Global Influenza Vaccine Sales Market Share by Application (2017-2022)
Figure 25. Global Influenza Vaccine Sales Market Share by Application in 2021
Figure 26. Global Influenza Vaccine Market Share by Application (2017-2022)
Figure 27. Global Influenza Vaccine Market Share by Application in 2020
Figure 28. Global Influenza Vaccine Sales Growth Rate by Application (2017-2022)
Figure 29. Global Influenza Vaccine Sales Market Share by Region (2017-2022)
Figure 30. North America Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Influenza Vaccine Sales Market Share by Country in 2020
Figure 32. U.S. Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Influenza Vaccine Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Influenza Vaccine Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Influenza Vaccine Sales Market Share by Country in 2020
Figure 37. Germany Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Influenza Vaccine Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Influenza Vaccine Sales Market Share by Region in 2020
Figure 44. China Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Influenza Vaccine Sales and Growth Rate (K Units)
Figure 50. South America Influenza Vaccine Sales Market Share by Country in 2020
Figure 51. Brazil Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Influenza Vaccine Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Influenza Vaccine Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Influenza Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Influenza Vaccine Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Influenza Vaccine Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Influenza Vaccine Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Influenza Vaccine Market Share Forecast by Type (2022-2028)
Figure 65. Global Influenza Vaccine Sales Forecast by Application (2022-2028)
Figure 66. Global Influenza Vaccine Market Share Forecast by Application (2022-2028)

Key Players
•CSL
•GSK
•Sanofi Pasteur
•Mylan
•Hulan Bio
•AstraZeneca
•CCBIO

Speak With Analyst

Name

Corporate Email ID

Country

Phone No.

Your Message

Report Details

Speak With Analyst